COVID-19 Information & Resources
For pharmacy specific information, see: COVID-19 UPDATED Oregon Board of Pharmacy Information 5/22/2020
On 6/15/2020, the FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 when a clinical trial was unavailable, or participation in a clinical trial was not feasible. The agency determined that the legal criteria for issuing an EUA are no longer met.
Based on its ongoing analysis of the EUA and emerging scientific data, the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA. Additionally, in light of ongoing serious cardiac adverse events and other potential serious side effects, the known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorized use.
In light of this FDA action, the Board of Pharmacy has modified its rule (OAR 855-007-0085
) for the dispensing of chloroquine and hydroxychloroquine during the public health emergency.
Note: The temporary rule does not regulate any use of CQ/HCQ other than prohibiting dispensing for COVID-19. The rule does not require a diagnosis code to be documented, however it may be useful for the pharmacist to perform a comprehensive DUR.
On 7/2/2020, the Oregon Health Authority provided the following memo and guidance related to Remdesivir allocation:
Additional Public Health Emergency Information
In order to help contain the spread of the coronavirus (COVID-19), the Oregon Board of Pharmacy has closed its offices to the general public and Board staff will be following the physical distancing measures outlined in Governor Brown’s Executive Order No. 20-12.
If you need to contact the Board for any reason, use one of the email addresses listed below:
Please be advised that it may take longer than usual to receive a response, however staff will reply as soon as possible.
For the latest information on Novel Coronavirus (COVID-19) in Oregon, visit the Oregon Health Authority.